Showing results (181-190 of 205) with videos related to
Sort By:
Pageof 21
Marine Pollution Bulletin|November 20, 2013
One size does not fit all: the emerging frontier in large-scale marine conservationRobert J Toonen, T 'Aulani Wilhelm, Sara M Maxwell, et al.BMC Cancer|September 8, 2009
Reversal of oncogene transformation and suppression of tumor growth by the novel IGF1R kinase inhibitor A-928605William N Pappano, Paul M Jung, Jonathan A Meulbroek, et al.Journal of Enzyme Inhibition|October 28, 1999
Evaluation of the inhibition of other metalloproteinases by matrix metalloproteinase inhibitorsP A Marcotte, I N Elmore, Z Guan, et al.Bioorganic & Medicinal Chemistry Letters|February 17, 2009
Development of multitargeted inhibitors of both the insulin-like growth factor receptor (IGF-IR) and members of the epidermal growth factor family of receptor tyrosine kinasesRobert D Hubbard, Nwe Y Bamaung, Steve D Fidanze, et al.Developmental Cell|December 24, 2014
Reverse genetic screening reveals poor correlation between morpholino-induced and mutant phenotypes in zebrafishF O Kok, M Shin, C-W Ni, et al.Cancer Research|November 25, 2003
Tumor suppression by a rationally designed reversible inhibitor of methionine aminopeptidase-2Jieyi Wang, George S Sheppard, Pingping Lou, et al.Nature Biomedical Engineering|March 5, 2025
A positron emission tomography tracer for the imaging of oxidative stress in the central nervous systemJustin H Wilde, Yu-Yo Sun, Spenser R Simpson, et al.Bioorganic & Medicinal Chemistry Letters|April 25, 2006
Development of sulfonamide compounds as potent methionine aminopeptidase type II inhibitors with antiproliferative propertiesMegumi Kawai, Nwe Y BaMaung, Steve D Fidanze, et al.Journal of Cancer Research and Clinical Oncology|August 20, 2022
FLOT and CROSS chemotherapy regimens alter the frequency of CD27+ and CD69+ T cells in oesophagogastric adenocarcinomas: implications for combination with immunotherapyMaria Davern, Noel E Donlon, Andrew S Sheppard, et al.Journal of Medicinal Chemistry|April 24, 2020
Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second BromodomainGeorge S Sheppard, Le Wang, Steven D Fidanze, et al.Pageof 21